Tsugumine Shu
Director/Board Member at I'ROM GROUP CO., LTD.
Net worth: 510 685 $ as of 30/04/2024
Profile
Tsugumine Shu is currently the Director & Head-ISEL Bank Promotions at I'rom Group Co., Ltd.
since 2022 and the Director & Vice President at Id Pharma Co., Ltd.
since 2019.
Previously, he held positions as President at Beijing B&m Biotech Co., Ltd.
and Researcher at DNAVEC Research, Inc. Dr. Shu obtained a doctorate degree from Tokyo University of Agriculture & Technology in 1989.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
I'ROM GROUP CO., LTD.
0.36% | 31/03/2023 | 44,351 ( 0.36% ) | 510 685 $ | 30/04/2024 |
Tsugumine Shu active positions
| Companies | Position | Start |
|---|---|---|
| I'ROM GROUP CO., LTD. | Director/Board Member | 01/07/2016 |
Id Pharma Co., Ltd.
 Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | Director/Board Member | 01/04/2004 |
Former positions of Tsugumine Shu
| Companies | Position | End |
|---|---|---|
Beijing B&m Biotech Co., Ltd.
 Beijing B&m Biotech Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Part of JSR Corp., Beijing B & m Biotech Co., Ltd. is a private company that provides medical services and tools. The company is based in Beijing, China. | President | - |
| DNAVEC Research, Inc. | Corporate Officer/Principal | - |
Training of Tsugumine Shu
| Tokyo University of Agriculture & Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| I'ROM GROUP CO., LTD. | Health Services |
| Private companies | 3 |
|---|---|
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | Health Technology |
Beijing B&m Biotech Co., Ltd.
Beijing B&m Biotech Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Part of JSR Corp., Beijing B & m Biotech Co., Ltd. is a private company that provides medical services and tools. The company is based in Beijing, China. | Electronic Technology |
| DNAVEC Research, Inc. |
- Stock Market
- Insiders
- Tsugumine Shu